2025-05-09

#reports #MNTK

[Montauk Renewables, Inc.](https://eninvs.com/all.php?name=MNTK) (Utilities — Diversified) reported for 2025 q1
(2025-05-09, After Market Close):

- Revenue +10.3% YoY (vs 0.0% in previous quarter and historical rate +30.0%)
- EBITDA -12.5% YoY (vs -106.2% in previous quarter and historical rate +40.0%)
- EBITDA margin 16.3% decreased compared to 20.5% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.4% of market cap
- EV/EBITDA multiple is 9x compared to historical level (75th percentile) of 29.1x
- EV/Sales multiple is 1.9x

------------------------------------------------

2025-05-09

#reports #NET
@ cybersecurity

[Cloudflare](https://eninvs.com/all.php?name=NET) (Provides a secure connection to the Internet) reported for 2025 q1
(2025-05-08, After Market Close):

- Revenue +26.4% YoY (vs +27.1% in previous quarter and historical rate +34.8%)
- EBITDA margin 2.5% increased compared to -1.6% same period last year
- Net Debt decreased by $45 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 179.9x compared to historical level (75th percentile) of 3019.5x
- EV/Sales multiple is 23.8x

------------------------------------------------

2025-05-08

#reports #ZVIA

[Zevia PBC](https://eninvs.com/all.php?name=ZVIA) (Beverages — Non-Alcoholic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184618)
(2025-05-07, After Market Close):

- Revenue -2.6% YoY (vs +2.6% in previous quarter and historical rate -1.7%)
- EBITDA margin -15.8% increased compared to -17.9% same period last year
- Net Debt increased by $8 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0 bln (negative), 6.7% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-05-08

#reports #XPER

[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -4.2% YoY (vs -10.9% in previous quarter and historical rate -16.1%)
- EBITDA margin -12.3% increased compared to -24.4% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 2.7% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-05-08

#reports #VRSK

[Verisk Analytics](https://eninvs.com/all.php?name=VRSK) (Analytical service provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184614)
(2025-05-07, Before Market Open):

- Revenue +7% YoY (vs +8.7% in previous quarter and historical rate -0.8%)
- EBITDA +5.5% YoY (vs -52.4% in previous quarter and historical rate +3.1%)
- EBITDA margin 58.8% decreased compared to 59.7% same period last year
- Net Debt decreased by $136 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 28.4x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 16x

At the opening of the session the share price went up +2.2% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #VRRM

[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184613)
(2025-05-07, After Market Close):

- Revenue +6.2% YoY (vs +5.2% in previous quarter and historical rate +12.9%)
- EBITDA +4.9% YoY (vs -132.0% in previous quarter and historical rate -5.1%)
- EBITDA margin 38.1% decreased compared to 38.6% same period last year
- Net Debt decreased by $32 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 18.4x compared to historical level (75th percentile) of 17.2x
- EV/Sales multiple is 5.1x

------------------------------------------------

2025-05-08

#reports #VNDA

[Vanda Pharmaceuticals](https://eninvs.com/all.php?name=VNDA) (Small molecule drugs developer) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +6.4% YoY (vs +17.8% in previous quarter and historical rate -6.8%)
- EBITDA margin -82.0% decreased compared to -19.1% same period last year
- Net Debt increased by $33 mln over the past reporting period (13.0% of market cap)
- FCF (LTM) -$0 bln (negative), 8.2% of market cap
- EV/EBITDA multiple is 1.1x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is -0.4x

------------------------------------------------

2025-05-08

#reports #VECO

[Veeco Instruments](https://eninvs.com/all.php?name=VECO) (Semiconductor Equipment and Materials) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184611)
(2025-05-07, After Market Close):

- Revenue -4% YoY (vs +4.6% in previous quarter and historical rate +5.6%)
- EBITDA -32.1% YoY (vs -71.4% in previous quarter and historical rate -1.3%)
- EBITDA margin 11.4% decreased compared to 16.1% same period last year
- Net Debt decreased by $36 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.4% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 18.6x
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-05-08

#reports #VCYT

[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +17.5% YoY (vs +21.4% in previous quarter and historical rate +23.0%)
- EBITDA margin 7.0% increased compared to 1.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 46.9x compared to historical level (75th percentile) of 70.3x
- EV/Sales multiple is 4.7x

------------------------------------------------

2025-05-08

#reports #UTI

[Universal Technical Institute](https://eninvs.com/all.php?name=UTI) (Education and Training Services) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +12.5% YoY (vs +14.9% in previous quarter and historical rate +36.1%)
- EBITDA +72.2% YoY (vs +66.7% in previous quarter and historical rate +51.9%)
- EBITDA margin 15.0% increased compared to 9.8% same period last year
- Net Debt increased by $47 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-05-08

#reports #UFPT

[UFP Technologies](https://eninvs.com/all.php?name=UFPT) (Medical Devices) reported for 2025 q1
(2025-05-06, Before Market Open):

- Revenue +41% YoY (vs +42.6% in previous quarter and historical rate +36.7%)
- EBITDA +36.8% YoY (vs +66.7% in previous quarter and historical rate +53.2%)
- EBITDA margin 17.6% decreased compared to 18.1% same period last year
- Net Debt decreased by $7 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 9.2% of market cap
- EV/EBITDA multiple is 18.1x compared to historical level (75th percentile) of 26.7x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +10.4% vs S&P500 -0.8%

------------------------------------------------

2025-05-08

#reports #UBER

[Uber Technologies](https://eninvs.com/all.php?name=UBER) (Ride hailing services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184610)
(2025-05-07, Before Market Open):

- Revenue +13.8% YoY (vs +20.4% in previous quarter and historical rate +31.8%)
- EBITDA +284.2% YoY (vs +10.6% in previous quarter and historical rate +77.8%)
- EBITDA margin 12.2% increased compared to 3.6% same period last year
- Net Debt increased by $961 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$5 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 37.2x compared to historical level (75th percentile) of 82.6x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -3.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #TRIP

[TripAdvisor](https://eninvs.com/all.php?name=TRIP) (Travel services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184606)
(2025-05-07, Before Market Open):

- Revenue +0.8% YoY (vs +5.4% in previous quarter and historical rate +22.9%)
- EBITDA -14.3% YoY (vs -58.9% in previous quarter and historical rate +31.8%)
- EBITDA margin 1.5% decreased compared to 1.8% same period last year
- Net Debt increased by $267 mln over the past reporting period (13.2% of market cap)
- FCF (LTM) -$0.4 bln (negative), 20.0% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +1.9% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #STAA

[STAAR Surgical Co](https://eninvs.com/all.php?name=STAA) (Implantable contact lenses manufacturer ) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184471)
(2025-05-07, After Market Close):

- Revenue -44.2% YoY (vs -35.5% in previous quarter and historical rate +5.8%)
- EBITDA margin -127.9% decreased compared to -1.3% same period last year
- Net Debt decreased by $31 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.2% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-05-08

#reports #SMSI

[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for 2025 q1
(2024-08-01, After Market Close):

- Revenue -16.7% YoY (vs -44.4% in previous quarter and historical rate -28.9%)
- EBITDA margin -80.0% increased compared to -500.0% same period last year
- EV/Sales multiple is 3.9x

At the opening of the session the share price went down -18.5% vs S&P500 -1.3%

------------------------------------------------

2025-05-08

#reports #SLNG

[Stabilis Solutions](https://eninvs.com/all.php?name=SLNG) (Oil and Gas Integrated) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184595)
(2025-05-07, After Market Close):

- Revenue -15% YoY (vs -5.6% in previous quarter and historical rate +5.1%)
- EBITDA -100% YoY (vs 0.0% in previous quarter and historical rate +9.7%)
- EV/EBITDA multiple is 20.8x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 1.5x

------------------------------------------------

2025-05-08

#reports #SGU

[Star Group](https://eninvs.com/all.php?name=SGU) (Oil and Gas Midstream) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184593)
(2025-05-05, After Market Close):

- Revenue +11.6% YoY (vs -7.6% in previous quarter and historical rate +3.5%)
- EBITDA +24.1% YoY (vs +90.0% in previous quarter and historical rate +9.7%)
- EBITDA margin 18.0% increased compared to 16.2% same period last year
- Net Debt decreased by $9 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 10.5% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +0.1% vs S&P500 -0.8%

------------------------------------------------

2025-05-08

#reports #SEMR

[Semrush Holdings, Inc.](https://eninvs.com/all.php?name=SEMR) (Software — Application) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +22.1% YoY (vs +24.1% in previous quarter and historical rate +24.8%)
- EBITDA 0% YoY (vs +225.0% in previous quarter)
- EBITDA margin 5.7% decreased compared to 7.0% same period last year
- Net Debt decreased by $25 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 36.1x compared to historical level (75th percentile) of 102x
- EV/Sales multiple is 3.1x

------------------------------------------------

2025-05-08

#reports #SDGR

[Schrodinger/United States](https://eninvs.com/all.php?name=SDGR) (Software developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184591)
(2025-05-07, After Market Close):

- Revenue +62.2% YoY (vs -50.0% in previous quarter and historical rate +2.2%)
- EBITDA margin -81.7% increased compared to -178.4% same period last year
- Net Debt decreased by $150 mln over the past reporting period (8.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.7% of market cap
- EV/Sales multiple is 9.1x

------------------------------------------------

2025-05-08

#reports #SCL

[Stepan Company](https://eninvs.com/all.php?name=SCL) (Specialty and intermediate chemicals manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184890)
(2025-04-29, Before Market Open):

- Revenue -22% YoY (vs -1.1% in previous quarter and historical rate -5.0%)
- EBITDA +41.5% YoY (vs +53.3% in previous quarter and historical rate +6.3%)
- EBITDA margin 13.5% increased compared to 7.4% same period last year
- Net Debt increased by $276 mln over the past reporting period (22.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 17.1% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 19.8x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +6.2% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #SABR

[Sabre](https://eninvs.com/all.php?name=SABR) (Information Technology Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184590)
(2025-05-07, Before Market Open):

- Revenue -0.8% YoY (vs +4.1% in previous quarter and historical rate +17.4%)
- EBITDA +3.6% YoY (vs +40.8% in previous quarter and historical rate +75.5%)
- EBITDA margin 18.4% increased compared to 17.6% same period last year
- Net Debt increased by $126 mln over the past reporting period (13.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 37x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went down -0.8% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #RYTM

[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184589)
(2025-05-07, Before Market Open):

- Revenue +46.2% YoY (vs +75.0% in previous quarter and historical rate +143.4%)
- EBITDA margin -126.3% increased compared to -534.6% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.4 bln (negative), 10.5% of market cap
- EV/Sales multiple is 29.6x

At the opening of the session the share price went down -2.6% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #RXST

[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184588)
(2025-05-07, After Market Close):

- Revenue +26.7% YoY (vs +37.9% in previous quarter and historical rate +74.0%)
- EBITDA margin -26.3% increased compared to -33.3% same period last year
- Net Debt increased by $8 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 22.8% of market cap
- EV/Sales multiple is 1.3x

------------------------------------------------

2025-05-08

#reports #RMBL

[RumbleON](https://eninvs.com/all.php?name=RMBL) (Auto and Truck Dealerships) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue -20.5% YoY (vs -13.2% in previous quarter and historical rate +10.7%)
- EBITDA -33.3% YoY (vs -3700.0% in previous quarter and historical rate +22.7%)
- EBITDA margin 2.4% decreased compared to 2.9% same period last year
- Net Debt increased by $39 mln over the past reporting period (46.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 102.5% of market cap
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -5.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #RELY

[Remitly Global, Inc.](https://eninvs.com/all.php?name=RELY) (Software — Infrastructure) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184583)
(2025-05-07, After Market Close):

- Revenue +34.6% YoY (vs +32.8% in previous quarter and historical rate +54.6%)
- EBITDA margin 5.0% increased compared to -5.9% same period last year
- Net Debt decreased by $121 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.9% of market cap
- EV/Sales multiple is 2x

------------------------------------------------

2025-05-08

#reports #QTWO

[Q2](https://eninvs.com/all.php?name=QTWO) (Online banking services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184580)
(2025-05-07, After Market Close):

- Revenue +14.5% YoY (vs +13.0% in previous quarter and historical rate +11.7%)
- EBITDA +130% YoY (vs +144.4% in previous quarter and historical rate +122.9%)
- EBITDA margin 12.1% increased compared to 6.0% same period last year
- Net Debt decreased by $39 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 73.6x compared to historical level (75th percentile) of 769.8x
- EV/Sales multiple is 6.7x

------------------------------------------------

2025-05-08

#reports #QRTEB

[Qurate Retail](https://eninvs.com/all.php?name=QRTEB) (Internet Retail) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184675)
(2025-02-27, After Market Close):

- Revenue -10.1% YoY (vs -6.3% in previous quarter and historical rate -2.2%)
- EBITDA -52.5% YoY (vs -117900.0% in previous quarter and historical rate +1.3%)
- EBITDA margin 5.5% decreased compared to 10.4% same period last year
- Net Debt increased by $100 mln over the past reporting period (35.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 91.2% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +425.0% vs S&P500 -0.3%

------------------------------------------------

2025-05-08

#reports #QNST

[QuinStreet](https://eninvs.com/all.php?name=QNST) (Marketing services provider ) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +59.8% YoY (vs +130.1% in previous quarter and historical rate +28.4%)
- EBITDA margin 4.1% increased compared to 0.6% same period last year
- Net Debt decreased by $23 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 35.5x compared to historical level (75th percentile) of 740x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-05-08

#reports #PBPB

[Potbelly Corporation](https://eninvs.com/all.php?name=PBPB) (Restaurants) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +2.7% YoY (vs -7.1% in previous quarter and historical rate +5.7%)
- EBITDA +33.3% YoY (vs -14.3% in previous quarter and historical rate +83.4%)
- EBITDA margin 3.5% increased compared to 2.7% same period last year
- Net Debt decreased by $5 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0 bln (positive), 6.2% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-05-08

#reports #ONTF

[ON24, Inc.](https://eninvs.com/all.php?name=ONTF) (Software — Application) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -7.9% YoY (vs -5.1% in previous quarter and historical rate -10.2%)
- EBITDA margin -17.1% increased compared to -18.4% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 5.4% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2025-05-08

#reports #OEC

[Orion Engineered Carbons](https://eninvs.com/all.php?name=OEC) (Specialty Chemicals) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -5% YoY (vs -7.3% in previous quarter and historical rate +4.8%)
- EBITDA -27.5% YoY (vs -14.0% in previous quarter and historical rate -10.5%)
- EBITDA margin 12.1% decreased compared to 15.9% same period last year
- Net Debt increased by $73 mln over the past reporting period (11.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 22.4% of market cap
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 7.6x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-05-08

#reports #ODP

[Office Depot](https://eninvs.com/all.php?name=ODP) (Specialty Retail) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184571)
(2025-05-07, Before Market Open):

- Revenue -9.2% YoY (vs -10.2% in previous quarter and historical rate -7.6%)
- EBITDA -110.6% YoY (vs +7000.0% in previous quarter and historical rate +7.4%)
- EBITDA margin -0.3% decreased compared to 2.5% same period last year
- Net Debt decreased by $79 mln over the past reporting period (11.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 27.0% of market cap
- EV/EBITDA multiple is 7.1x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +20.2% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #OC

[Owens Corning](https://eninvs.com/all.php?name=OC) (Building products manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184570)
(2025-05-07, Before Market Open):

- Revenue +10% YoY (vs +342.1% in previous quarter and historical rate +22.9%)
- EBITDA +5.8% YoY (vs +123.3% in previous quarter and historical rate +14.2%)
- EBITDA margin 22.2% decreased compared to 23.0% same period last year
- Net Debt increased by $348 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$3.2 bln (negative), 25.5% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 8.1x
- EV/Sales multiple is 1x

At the opening of the session the share price went down -2.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #NOTV

[Inotiv](https://eninvs.com/all.php?name=NOTV) (Diagnostics and Research) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +72.2% YoY (vs +31.9% in previous quarter and historical rate +33.0%)
- EBITDA margin 8.9% increased compared to -27.8% same period last year
- Net Debt increased by $20 mln over the past reporting period (36.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 338.9% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 98.6x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-05-08

#reports #MUSA

[Murphy USA](https://eninvs.com/all.php?name=MUSA) (Motor fuel supplier) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -6.6% YoY (vs -7.1% in previous quarter and historical rate +3.2%)
- EBITDA -4.9% YoY (vs -2.9% in previous quarter and historical rate +8.9%)
- EBITDA margin 3.4% has not changed compared to 3.4% same period last year
- Net Debt increased by $136 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-05-08

#reports #MQ

[Marqeta, Inc.](https://eninvs.com/all.php?name=MQ) (Software — Infrastructure) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +17.8% YoY (vs +14.3% in previous quarter and historical rate +4.8%)
- EBITDA margin -9.4% increased compared to -39.0% same period last year
- Net Debt increased by $114 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.6% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 20.3x
- EV/Sales multiple is 2.1x

------------------------------------------------

2025-05-08

#reports #MMI

[Marcus & Millichap](https://eninvs.com/all.php?name=MMI) (Investment brokerage company) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue +12.4% YoY (vs +44.6% in previous quarter and historical rate -13.8%)
- EBITDA margin -10.3% increased compared to -13.2% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.0% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +4.4% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #MKSI

[MKS Instruments](https://eninvs.com/all.php?name=MKSI) (Gas monitoring and analysis instruments supplier) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +7.8% YoY (vs +4.7% in previous quarter and historical rate +8.1%)
- EBITDA +1% YoY (vs +86.6% in previous quarter and historical rate +12.3%)
- EBITDA margin 20.9% decreased compared to 22.4% same period last year
- Net Debt decreased by $20 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 6.0% of market cap
- EV/EBITDA multiple is 9.6x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-05-08

#reports #MEG

[Montrose Environmental Group](https://eninvs.com/all.php?name=MEG) (Waste Management) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +14.8% YoY (vs +13.9% in previous quarter and historical rate +9.9%)
- EBITDA +50% YoY (vs -333.3% in previous quarter and historical rate -12.4%)
- EBITDA margin 1.7% increased compared to 1.3% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 100x compared to historical level (75th percentile) of 356.5x
- EV/Sales multiple is 2.5x

------------------------------------------------

2025-05-08

#reports #LPSN

[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for 2025 q1
(2025-03-05, After Market Close):

- Revenue -23.5% YoY (vs -23.2% in previous quarter and historical rate -12.0%)
- EBITDA margin -16.9% increased compared to -32.9% same period last year
- Net Debt increased by $536 mln over the past reporting period (775.7% of market cap)
- FCF (LTM) +$0.6 bln (positive), 827.8% of market cap
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -13.6% vs S&P500 -1.0%

------------------------------------------------

2025-05-08

#reports #LNTH

[Lantheus](https://eninvs.com/all.php?name=LNTH) (Medicine equipment developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184554)
(2025-05-07, Before Market Open):

- Revenue +0.8% YoY (vs +10.5% in previous quarter and historical rate +49.1%)
- EBITDA -4.2% YoY (vs -16.4% in previous quarter and historical rate +67.9%)
- EBITDA margin 30.6% decreased compared to 32.2% same period last year
- Net Debt decreased by $25 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 10.3x compared to historical level (75th percentile) of 62.9x
- EV/Sales multiple is 3.4x

At the opening of the session the share price went down -14.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #LIVN

[LivaNova](https://eninvs.com/all.php?name=LIVN) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184553)
(2025-05-07, Before Market Open):

- Revenue +7.5% YoY (vs +201.6% in previous quarter and historical rate +24.0%)
- EBITDA +188.9% YoY (vs +9200.0% in previous quarter and historical rate +47.1%)
- EBITDA margin 16.4% increased compared to 6.1% same period last year
- Net Debt decreased by $316 mln over the past reporting period (13.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 10.1x compared to historical level (75th percentile) of 366.3x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +12.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #LFST

[LifeStance Health Group, Inc.](https://eninvs.com/all.php?name=LFST) (Medical Care Facilities) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184551)
(2025-05-07, Before Market Open):

- Revenue +11% YoY (vs +15.7% in previous quarter and historical rate +15.8%)
- EBITDA +150% YoY (vs +1500.0% in previous quarter and historical rate +79.2%)
- EBITDA margin 4.5% increased compared to 2.0% same period last year
- Net Debt increased by $16 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.5% of market cap
- EV/EBITDA multiple is 49x compared to historical level (75th percentile) of 228.5x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -6.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #LBRDK

[Liberty Broadband (K)](https://eninvs.com/all.php?name=LBRDK) ( Multinational telecommunications company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184745)
(2025-05-07, Before Market Open):

- Revenue +8.6% YoY (vs +5.2% in previous quarter and historical rate +2.0%)
- EBITDA +23.1% YoY (vs -14.9% in previous quarter and historical rate +3.8%)
- EBITDA margin 36.1% increased compared to 31.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 60.1x compared to historical level (75th percentile) of 63.8x
- EV/Sales multiple is 18.4x

At the opening of the session the share price went down -0.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #LAW

[CS Disco, Inc.](https://eninvs.com/all.php?name=LAW) (Software — Application) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +2.8% YoY (vs +2.8% in previous quarter and historical rate +4.7%)
- EBITDA margin -29.7% increased compared to -30.6% same period last year
- Net Debt increased by $10 mln over the past reporting period (4.7% of market cap)
- FCF (LTM) -$0 bln (negative), 9.4% of market cap
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-05-08

#reports #KVHI

[KVH Industries](https://eninvs.com/all.php?name=KVHI) (Communication Equipment) reported for 2025 q1
(2025-05-05, Before Market Open):

- Revenue -13.8% YoY (vs -12.9% in previous quarter and historical rate -13.2%)
- EBITDA margin 4.0% increased compared to -3.4% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 16.4% of market cap
- EV/EBITDA multiple is 4.5x compared to historical level (75th percentile) of 15.7x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -0.4% vs S&P500 -0.6%

------------------------------------------------

2025-05-08

#reports #KTOS

[Kratos](https://eninvs.com/all.php?name=KTOS) (Security services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184547)
(2025-05-07, After Market Close):

- Revenue +9.4% YoY (vs +3.3% in previous quarter and historical rate +12.8%)
- EBITDA +112.5% YoY (vs -87.5% in previous quarter and historical rate +58.8%)
- EBITDA margin 5.6% increased compared to 2.9% same period last year
- Net Debt increased by $67 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 73x compared to historical level (75th percentile) of 58.8x
- EV/Sales multiple is 3.9x

------------------------------------------------

2025-05-08

#reports #KRO

[Kronos Worldwide](https://eninvs.com/all.php?name=KRO) (Specialty Chemicals) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184546)
(2025-05-07, After Market Close):

- Revenue +2.3% YoY (vs +5.8% in previous quarter and historical rate -0.1%)
- EBITDA +57.6% YoY (vs +616.7% in previous quarter and historical rate +52.4%)
- EBITDA margin 10.6% increased compared to 6.9% same period last year
- Net Debt increased by $214 mln over the past reporting period (25.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 27.1% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 23x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-05-08

#reports #KMT

[Kennametal](https://eninvs.com/all.php?name=KMT) (Equipment for metal cutting manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184545)
(2025-05-07, Before Market Open):

- Revenue -5.8% YoY (vs -2.6% in previous quarter and historical rate -0.1%)
- EBITDA +23.1% YoY (vs +9.4% in previous quarter and historical rate -3.9%)
- EBITDA margin 9.9% increased compared to 7.6% same period last year
- Net Debt increased by $37 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 11.5x
- EV/Sales multiple is 1x

At the opening of the session the share price went up +7.2% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #KIDS

[OrthoPediatrics](https://eninvs.com/all.php?name=KIDS) (Medical equipment developer) reported for 2025 q1
(2025-03-04, After Market Close):

- Revenue +15.6% YoY (vs +39.5% in previous quarter and historical rate +29.1%)
- EBITDA margin -13.5% decreased compared to -13.3% same period last year
- Net Debt increased by $10 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 8.0% of market cap
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -2.7% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #KAR

[KAR Auction Services](https://eninvs.com/all.php?name=KAR) (Specialty Retail) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +10.6% YoY (vs +25.8% in previous quarter and historical rate -1.1%)
- EBITDA -21.3% YoY (vs -91.6% in previous quarter and historical rate -17.6%)
- EBITDA margin 16.1% decreased compared to 22.6% same period last year
- Net Debt increased by $139 mln over the past reporting period (6.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 10.3% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 20.5x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-05-08

#reports #JLL

[Jones Lang LaSalle](https://eninvs.com/all.php?name=JLL) (Real estate service provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184543)
(2025-05-07, Before Market Open):

- Revenue +12.1% YoY (vs +15.8% in previous quarter and historical rate +6.5%)
- EBITDA -21.1% YoY (vs +25.0% in previous quarter and historical rate -0.1%)
- EBITDA margin 2.4% decreased compared to 3.4% same period last year
- Net Debt increased by $956 mln over the past reporting period (8.8% of market cap)
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -4.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2025 q1
(2025-05-05, Before Market Open):

- Revenue -45.3% YoY (vs -22.9% in previous quarter and historical rate -8.9%)
- EBITDA -333.3% YoY (vs -12.0% in previous quarter and historical rate -23.9%)
- EBITDA margin -68.3% decreased compared to 16.0% same period last year
- Net Debt decreased by $219 mln over the past reporting period (179.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 115.7% of market cap
- EV/EBITDA multiple is 5.1x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -0.2% vs S&P500 -0.6%

------------------------------------------------

2025-05-08

#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -77.3% YoY (vs -75.9% in previous quarter and historical rate -23.8%)
- EBITDA margin -60.0% decreased compared to -13.6% same period last year
- Net Debt increased by $3 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 159.5% of market cap
- EV/EBITDA multiple is 2.6x compared to historical level (75th percentile) of 82x
- EV/Sales multiple is -2.2x

------------------------------------------------

2025-05-08

#reports #INVA

[Innoviva](https://eninvs.com/all.php?name=INVA) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184541)
(2025-02-24, After Market Close):

- Revenue +15.6% YoY (vs +7.0% in previous quarter and historical rate +0.7%)
- EBITDA -11.8% YoY (vs -91.0% in previous quarter and historical rate +8.4%)
- EBITDA margin 50.6% decreased compared to 66.2% same period last year
- Net Debt decreased by $16 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 11.8% of market cap
- EV/EBITDA multiple is 22.9x compared to historical level (75th percentile) of 5.2x
- EV/Sales multiple is 3.5x

At the opening of the session the share price went down -1.1% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #INGN

[Inogen](https://eninvs.com/all.php?name=INGN) (Medical products manufacturer) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +5.1% YoY (vs +5.3% in previous quarter and historical rate -0.1%)
- EBITDA margin -2.4% increased compared to -14.1% same period last year
- Net Debt decreased by $6 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/Sales multiple is 0.2x

------------------------------------------------

2025-05-08

#reports #INFA

[Informatica Inc.](https://eninvs.com/all.php?name=INFA) (Software — Infrastructure) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +3.9% YoY (vs -3.8% in previous quarter and historical rate +3.7%)
- EBITDA +640% YoY (vs +59.5% in previous quarter)
- EBITDA margin 9.2% increased compared to 1.3% same period last year
- Net Debt decreased by $23 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.3 bln (positive), 4.5% of market cap
- EV/EBITDA multiple is 37.1x compared to historical level (75th percentile) of 198.1x
- EV/Sales multiple is 3.9x

------------------------------------------------

2025-05-08

#reports #HNST

[The Honest Company, Inc.](https://eninvs.com/all.php?name=HNST) (Specialty Retail) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +12.8% YoY (vs +11.1% in previous quarter and historical rate +8.4%)
- EBITDA margin 3.1% increased compared to -1.2% same period last year
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 51.8x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-05-08

#reports #HDSN

[Hudson Technologies](https://eninvs.com/all.php?name=HDSN) (Specialty Chemicals) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -15.4% YoY (vs -22.2% in previous quarter and historical rate +1.0%)
- EBITDA -71.4% YoY (vs -160.0% in previous quarter and historical rate -20.8%)
- EBITDA margin 7.3% decreased compared to 21.5% same period last year
- Net Debt decreased by $12 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 23.6% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 6.4x
- EV/Sales multiple is 1x

------------------------------------------------

2025-05-08

#reports #HCAT

[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +5.3% YoY (vs +6.7% in previous quarter and historical rate +7.0%)
- EBITDA margin -10.1% increased compared to -16.0% same period last year
- Net Debt increased by $50 mln over the past reporting period (20.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 54.1% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-05-08

#reports #GOLF

[Acushnet](https://eninvs.com/all.php?name=GOLF) (Golf products supplier) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184468)
(2025-05-07, Before Market Open):

- Revenue -0.7% YoY (vs +7.7% in previous quarter and historical rate +4.1%)
- EBITDA -6% YoY (vs -600.0% in previous quarter and historical rate +8.7%)
- EBITDA margin 17.9% decreased compared to 18.9% same period last year
- Net Debt increased by $165 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 16.4x compared to historical level (75th percentile) of 15.4x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went up +0.9% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #GDRX

[GoodRx](https://eninvs.com/all.php?name=GDRX) (Digital healthcare platform) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184528)
(2025-05-07, After Market Close):

- Revenue +2.5% YoY (vs +1.0% in previous quarter and historical rate +0.7%)
- EBITDA +26.1% YoY (vs +48.0% in previous quarter and historical rate +24.5%)
- EBITDA margin 14.3% increased compared to 11.6% same period last year
- Net Debt increased by $145 mln over the past reporting period (9.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 42.2x
- EV/Sales multiple is 2.1x

------------------------------------------------

2025-05-08

#reports #FWRD

[Forward Air](https://eninvs.com/all.php?name=FWRD) (Transportation services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184527)
(2025-02-26, After Market Close):

- Revenue +13.1% YoY (vs +87.3% in previous quarter and historical rate +18.0%)
- EBITDA margin 6.9% increased compared to -6.3% same period last year
- Net Debt decreased by $16 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 41.5% of market cap
- EV/Sales multiple is 1x

At the opening of the session the share price went down -11.4% vs S&P500 +0.3%

------------------------------------------------

2025-05-08

#reports #FSLY

[Fastly](https://eninvs.com/all.php?name=FSLY) (Infrastructure software developer) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +7.5% YoY (vs +2.2% in previous quarter and historical rate +14.5%)
- EBITDA margin -16.0% increased compared to -24.6% same period last year
- Net Debt decreased by $14 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/Sales multiple is 1.5x

------------------------------------------------

2025-05-08

#reports #EYPT

[EyePoint Pharmaceuticals](https://eninvs.com/all.php?name=EYPT) (Biotechnology) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue +100% YoY (vs -14.3% in previous quarter and historical rate +15.5%)
- EBITDA margin -208.3% increased compared to -283.3% same period last year
- Net Debt increased by $53 mln over the past reporting period (13.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 29.8% of market cap
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +2.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #EYE

[National Vision](https://eninvs.com/all.php?name=EYE) (Optics supplier) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue -6.1% YoY (vs -13.6% in previous quarter and historical rate -3.4%)
- EBITDA +2% YoY (vs -107.1% in previous quarter)
- EBITDA margin 10.0% increased compared to 9.2% same period last year
- Net Debt decreased by $17 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.1% of market cap
- EV/EBITDA multiple is 16.8x compared to historical level (75th percentile) of 31.2x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +12.2% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #EVER

[EverQuote](https://eninvs.com/all.php?name=EVER) (Platform for communication with auto insurers) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184754)
(2025-05-05, After Market Close):

- Revenue +83.5% YoY (vs +162.5% in previous quarter and historical rate +27.2%)
- EBITDA +200% YoY (vs +1300.0% in previous quarter)
- EBITDA margin 5.4% increased compared to 3.3% same period last year
- Net Debt decreased by $122 mln over the past reporting period (15.0% of market cap)
- FCF (LTM) +$0 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 32.4x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -6.2% vs S&P500 -0.8%

------------------------------------------------

2025-05-08

#reports #ESTA

[Establishment Labs](https://eninvs.com/all.php?name=ESTA) (Medical Devices) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +10.8% YoY (vs +40.6% in previous quarter and historical rate +10.5%)
- EBITDA margin -34.1% decreased compared to -16.2% same period last year
- Net Debt increased by $22 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/Sales multiple is 6.6x

------------------------------------------------

2025-05-08

#reports #EOLS

[Evolus](https://eninvs.com/all.php?name=EOLS) (Drug Manufacturers — Specialty and Generic) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +16.9% YoY (vs +29.5% in previous quarter and historical rate +31.8%)
- EBITDA margin -20.3% decreased compared to -13.6% same period last year
- Net Debt increased by $19 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-05-08

#reports #ENTG

[Entegris](https://eninvs.com/all.php?name=ENTG) (Components/equipment for the semiconductor industry manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184522)
(2025-05-07, Before Market Open):

- Revenue +0.3% YoY (vs +4.7% in previous quarter and historical rate +13.2%)
- EBITDA +2.3% YoY (vs +25.1% in previous quarter and historical rate +14.9%)
- EBITDA margin 28.2% increased compared to 27.6% same period last year
- Net Debt increased by $59 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 24.2x
- EV/Sales multiple is 4.7x

At the opening of the session the share price went down -6.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #ELAN

[Elanco Animal Health](https://eninvs.com/all.php?name=ELAN) (Animal medicine manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184520)
(2025-05-07, Before Market Open):

- Revenue -1% YoY (vs -1.4% in previous quarter and historical rate -2.1%)
- EBITDA +28.7% YoY (vs 0.0% in previous quarter and historical rate +9.2%)
- EBITDA margin 9.4% increased compared to 7.2% same period last year
- Net Debt increased by $55 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$1.6 bln (positive), 27.5% of market cap
- EV/EBITDA multiple is 76.2x compared to historical level (75th percentile) of 35.1x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +13.9% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #EEFT

[Euronet Worldwide](https://eninvs.com/all.php?name=EEFT) (Financial services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184630)
(2025-04-24, After Market Close):

- Revenue +6.9% YoY (vs +9.3% in previous quarter and historical rate +9.8%)
- EBITDA +10.3% YoY (vs +18.3% in previous quarter and historical rate +22.1%)
- EBITDA margin 11.7% increased compared to 11.3% same period last year
- Net Debt increased by $955 mln over the past reporting period (19.2% of market cap)
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 11.1x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -0.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #EE

[Excelerate Energy, Inc.](https://eninvs.com/all.php?name=EE) (Utilities — Renewable) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +57.5% YoY (vs +14.6% in previous quarter and historical rate -19.4%)
- EBITDA +27.9% YoY (vs +27.7% in previous quarter and historical rate +24.0%)
- EBITDA margin 27.6% decreased compared to 34.0% same period last year
- Net Debt decreased by $69 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 12.6x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 4.3x

------------------------------------------------

2025-05-08

#reports #ECOR

[electroCore](https://eninvs.com/all.php?name=ECOR) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184724)
(2023-05-17, After Market Close):

- Revenue +40% YoY (vs +40.0% in previous quarter and historical rate +83.6%)
- EBITDA margin -42.9% increased compared to -80.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) -$0 bln (negative), 6.2% of market cap
- EV/Sales multiple is 1x

At the opening of the session the share price went up +0.1%

------------------------------------------------

2025-05-08

#reports #EBS

[Emergent BioSolutions](https://eninvs.com/all.php?name=EBS) (Medicines developer) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -26% YoY (vs -29.3% in previous quarter and historical rate -10.1%)
- EBITDA +10.3% YoY (vs +4200.0% in previous quarter and historical rate +3.7%)
- EBITDA margin 33.8% increased compared to 22.7% same period last year
- Net Debt increased by $517 mln over the past reporting period (217.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 131.8% of market cap
- EV/EBITDA multiple is 94.4x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-05-08

#reports #DGII

[Digi International](https://eninvs.com/all.php?name=DGII) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184513)
(2025-05-07, After Market Close):

- Revenue -2.8% YoY (vs -1.9% in previous quarter and historical rate +8.6%)
- EBITDA +42.9% YoY (vs +4.8% in previous quarter)
- EBITDA margin 19.0% increased compared to 13.0% same period last year
- Net Debt increased by $44 mln over the past reporting period (4.3% of market cap)
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 26.4x
- EV/Sales multiple is 2.6x

------------------------------------------------

2025-05-08

#reports #CYRX

[CryoPort](https://eninvs.com/all.php?name=CYRX) (Logistic services provider) reported for 2025 q1
(2025-03-04, After Market Close):

- Revenue -25.5% YoY (vs +5.3% in previous quarter and historical rate -0.3%)
- EBITDA margin -26.8% increased compared to -34.5% same period last year
- Net Debt increased by $10 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0 bln (negative), 8.2% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +10.1% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #CTVA

[Corteva](https://eninvs.com/all.php?name=CTVA) ( Agricultural products provider ) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -1.7% YoY (vs +7.3% in previous quarter and historical rate +1.6%)
- EBITDA +39.3% YoY (vs +39100.0% in previous quarter and historical rate -13.5%)
- EBITDA margin 24.2% increased compared to 17.1% same period last year
- Net Debt decreased by $77 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$1.2 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 2.3x

------------------------------------------------

2025-05-08

#reports #CSGS

[CSG Systems International](https://eninvs.com/all.php?name=CSGS) (Revenue management platform) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +1.4% YoY (vs +6.7% in previous quarter and historical rate +4.4%)
- EBITDA -4.1% YoY (vs +29.8% in previous quarter and historical rate +20.1%)
- EBITDA margin 15.7% decreased compared to 16.6% same period last year
- Net Debt increased by $25 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.6% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-05-08

#reports #CR

[Crane](https://eninvs.com/all.php?name=CR) (Engineering industrial products manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184823)
(2025-04-28, After Market Close):

- Revenue +5.1% YoY (vs +11.8% in previous quarter and historical rate -6.6%)
- EBITDA -22.8% YoY (vs -1.9% in previous quarter and historical rate +0.7%)
- EBITDA margin 18.5% decreased compared to 25.2% same period last year
- Net Debt increased by $46 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.6 bln (negative), 5.9% of market cap
- EV/EBITDA multiple is 21.4x compared to historical level (75th percentile) of 20x
- EV/Sales multiple is 5.3x

At the opening of the session the share price went up +7.6% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #CPRX

[Catalyst Pharmaceuticals](https://eninvs.com/all.php?name=CPRX) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184465)
(2025-05-07, After Market Close):

- Revenue +42.4% YoY (vs +27.9% in previous quarter and historical rate +57.4%)
- EBITDA +133.3% YoY (vs +50.0% in previous quarter and historical rate +62.3%)
- EBITDA margin 44.7% increased compared to 27.3% same period last year
- Net Debt decreased by $63 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 10.0% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 18.5x
- EV/Sales multiple is 4.1x

------------------------------------------------

2025-05-08

#reports #CPK

[Chesapeake Utilities Corporation](https://eninvs.com/all.php?name=CPK) (Utilities — Regulated Gas) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184510)
(2025-05-07, After Market Close):

- Revenue +21.5% YoY (vs +16.2% in previous quarter and historical rate +12.8%)
- EBITDA +12.4% YoY (vs +32.8% in previous quarter and historical rate +22.0%)
- EBITDA margin 36.5% decreased compared to 39.4% same period last year
- Net Debt increased by $29 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.2% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 15.9x
- EV/Sales multiple is 5.5x

------------------------------------------------

2025-05-08

#reports #CENX

[Century Aluminum](https://eninvs.com/all.php?name=CENX) (Aluminum) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +29.4% YoY (vs +23.2% in previous quarter and historical rate +1.1%)
- EBITDA +204.5% YoY (vs +38.8% in previous quarter and historical rate +42.5%)
- EBITDA margin 10.6% increased compared to 4.5% same period last year
- Net Debt decreased by $38 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.6% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 29.5x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-05-08

#reports #CDXC

[ChromaDex Corporation](https://eninvs.com/all.php?name=CDXC) (Biotechnology) reported for 2025 q1
(2025-03-04, After Market Close):

- Revenue +36.4% YoY (vs +38.1% in previous quarter and historical rate +18.2%)
- EBITDA margin 16.7% increased compared to -4.5% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 43.5x compared to historical level (75th percentile) of 226x
- EV/Sales multiple is 5.6x

At the opening of the session the share price went up +19.8% vs S&P500 -0.4%

------------------------------------------------

2025-05-08

#reports #CDW

[CDW](https://eninvs.com/all.php?name=CDW) (IT services provider) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue +6.7% YoY (vs +3.3% in previous quarter and historical rate -0.4%)
- EBITDA +8.5% YoY (vs -6.0% in previous quarter and historical rate +4.0%)
- EBITDA margin 8.1% increased compared to 8.0% same period last year
- Net Debt increased by $32 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.3 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 18.6x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -0.3% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #CDLX

[Cardlytics](https://eninvs.com/all.php?name=CDLX) (Marketing services provider ) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184503)
(2025-03-12, After Market Close):

- Revenue -8.8% YoY (vs -16.9% in previous quarter and historical rate 0.0%)
- EBITDA margin -12.9% increased compared to -25.0% same period last year
- Net Debt increased by $169 mln over the past reporting period (161.8% of market cap)
- EV/Sales multiple is 1x

At the opening of the session the share price went up +12.1% vs S&P500 -0.1%

------------------------------------------------

2025-05-08

#reports #CDAY

[Ceridian HCM](https://eninvs.com/all.php?name=CDAY) (HCM services operator ) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184778)
(2023-11-01, Before Market Open):

- Revenue +11.6% YoY (vs +16.3% in previous quarter and historical rate +18.8%)
- EBITDA +44.1% YoY (vs -13.8% in previous quarter and historical rate +101.5%)
- EBITDA margin 17.6% increased compared to 13.7% same period last year
- Net Debt decreased by $469 mln over the past reporting period (4.3% of market cap)
- EV/EBITDA multiple is 49.3x compared to historical level (75th percentile) of 271.1x
- EV/Sales multiple is 5.7x

At the opening of the session the share price went down -1.0%

------------------------------------------------

2025-05-08

#reports #CCRN

[Cross Country Healthcare](https://eninvs.com/all.php?name=CCRN) (Medical Care Facilities) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184501)
(2025-05-05, After Market Close):

- Revenue -22.7% YoY (vs -25.1% in previous quarter and historical rate -6.0%)
- EBITDA -50% YoY (vs -94.4% in previous quarter and historical rate -31.3%)
- EBITDA margin 1.4% decreased compared to 2.1% same period last year
- Net Debt decreased by $77 mln over the past reporting period (16.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 12.8% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -0.7% vs S&P500 -0.8%

------------------------------------------------

2025-05-08

#reports #CAR

[Avis Budget](https://eninvs.com/all.php?name=CAR) (Rental and Leasing Services) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -4.7% YoY (vs -2.0% in previous quarter and historical rate +4.4%)
- EBITDA -12.8% YoY (vs -83.7% in previous quarter and historical rate -13.1%)
- EBITDA margin 31.6% decreased compared to 34.6% same period last year
- Net Debt decreased by $279 mln over the past reporting period (12.6% of market cap)
- FCF (LTM) +$1.9 bln (positive), 87.7% of market cap
- EV/EBITDA multiple is 5.3x compared to historical level (75th percentile) of 4.8x
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-05-08

#reports #BROS

[Dutch Bros Inc.](https://eninvs.com/all.php?name=BROS) (Restaurants) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +29.1% YoY (vs +35.0% in previous quarter and historical rate +34.7%)
- EBITDA +10.6% YoY (vs +600.0% in previous quarter and historical rate +120.3%)
- EBITDA margin 14.6% decreased compared to 17.1% same period last year
- Net Debt increased by $26 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 53.8x compared to historical level (75th percentile) of 86.3x
- EV/Sales multiple is 5.7x

------------------------------------------------

2025-05-08

#reports #BRKR

[Bruker](https://eninvs.com/all.php?name=BRKR) ( Medical equipment manufacturer ) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184498)
(2025-05-07, Before Market Open):

- Revenue +10.9% YoY (vs +14.8% in previous quarter and historical rate +12.0%)
- EBITDA -18% YoY (vs -11.3% in previous quarter and historical rate -4.6%)
- EBITDA margin 10.2% decreased compared to 13.9% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.8 bln (negative), 12.7% of market cap
- EV/EBITDA multiple is 19.2x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -0.5% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #BMBL

[Bumble Inc.](https://eninvs.com/all.php?name=BMBL) (Software — Application) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue -7.8% YoY (vs -4.4% in previous quarter and historical rate +9.7%)
- EBITDA -18.2% YoY (vs +450.0% in previous quarter and historical rate +34.6%)
- EBITDA margin 21.9% decreased compared to 24.6% same period last year
- Net Debt increased by $17 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.9% of market cap
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-05-08

#reports #BLZE

[Backblaze, Inc.](https://eninvs.com/all.php?name=BLZE) (Software — Infrastructure) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +16.7% YoY (vs +17.2% in previous quarter and historical rate +22.8%)
- EBITDA margin -2.9% increased compared to -13.3% same period last year
- Net Debt increased by $4 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 13.4% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-05-08

#reports #BLMN

[Bloomin Brands](https://eninvs.com/all.php?name=BLMN) (Restaurants owner) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue -12.1% YoY (vs -18.6% in previous quarter and historical rate -0.4%)
- EBITDA -19.8% YoY (vs -42.5% in previous quarter and historical rate -18.7%)
- EBITDA margin 9.6% decreased compared to 10.5% same period last year
- Net Debt increased by $12 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.9% of market cap
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 3.2x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +6.1% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #BBSI

[Barrett Business Services](https://eninvs.com/all.php?name=BBSI) (Platform for the provision of consulting services) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +10.2% YoY (vs +10.1% in previous quarter and historical rate +6.1%)
- EBITDA margin -0.7% increased compared to -1.1% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-05-08

#reports #AXTA

[Axalta Coating Systems](https://eninvs.com/all.php?name=AXTA) (Paint and primer manufacturer) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue -2.5% YoY (vs +1.1% in previous quarter and historical rate +5.1%)
- EBITDA +30.2% YoY (vs +43.0% in previous quarter and historical rate +9.1%)
- EBITDA margin 19.5% increased compared to 14.6% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.0% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -4.4% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #AXON

[Axon Enterprise](https://eninvs.com/all.php?name=AXON) (Conducted energy weapons manufacturer ) reported for 2025 q1
(2025-05-07, After Market Close):

- Revenue +31% YoY (vs +33.1% in previous quarter and historical rate +34.2%)
- EBITDA -52.2% YoY (vs -95.8% in previous quarter and historical rate +34.3%)
- EBITDA margin 1.8% decreased compared to 5.0% same period last year
- Net Debt decreased by $109 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 489.5x compared to historical level (75th percentile) of 159.3x
- EV/Sales multiple is 20.2x

------------------------------------------------

2025-05-08

#reports #AWR

[American States Water Company](https://eninvs.com/all.php?name=AWR) (Water and electricity utility company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184491)
(2025-05-07, After Market Close):

- Revenue +9.6% YoY (vs +14.4% in previous quarter and historical rate +8.5%)
- EBITDA +14% YoY (vs +13.6% in previous quarter and historical rate +15.1%)
- EBITDA margin 38.5% increased compared to 37.0% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 16.7x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 6.5x

------------------------------------------------

2025-05-08

#reports #AVDX

[AvidXchange Holdings, Inc.](https://eninvs.com/all.php?name=AVDX) (Software — Infrastructure) reported for 2025 q1
(2025-05-07, Before Market Open):

- Revenue +1.9% YoY (vs +10.6% in previous quarter and historical rate +17.9%)
- EBITDA -100% YoY (vs +266.7% in previous quarter)
- EV/EBITDA multiple is 84.2x compared to historical level (75th percentile) of 94.3x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went up +18.4% vs S&P500 +0.1%

------------------------------------------------

2025-05-08

#reports #APLS

[Apellis Pharmaceuticals](https://eninvs.com/all.php?name=APLS) (Therapeutic drug developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184486)
(2025-05-07, Before Market Open):

- Revenue -2.9% YoY (vs +45.9% in previous quarter and historical rate +130.9%)
- EBITDA margin -49.7% decreased compared to -36.0% same period last year
- Net Debt decreased by $363 mln over the past reporting period (18.8% of market cap)
- FCF (LTM) +$0.4 bln (positive), 19.7% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -10.3% vs S&P500 +0.1%

Switch to company model in classical logic    *